Work

Supplementary Figure 1 from Genetic and Pharmacologic Evidence That mTOR Targeting Outweighs mTORC1 Inhibition as an Antimyeloma Strategy

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 64K, Supplementary Figure 1. Detection of phospho-proteins in myeloma patient cells.

DOI: 10.1158/1535-7163.22500841.v1

Authors: Xi Chen, Elena Díaz-Rodríguez, Enrique M. Ocio, Bruno Paiva, Deborah S. Mortensen, Antonia Lopez-Girona, Rajesh Chopra, Jesús San Miguel, Atanasio Pandiella

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362621536

Cites:

Cited by:

Related to: 10